About MINSHENG ROYAL FUND MANAGEMENT CO BIOTECHNOLOGY ETF CNY
Expense ratio
0.60%
Home page
Inception date
Aug 5, 2021
ISIN
CNE100004X99
Closely track the target index, pursue the minimization of tracking deviation and tracking err, and strive to achieve Long-term investment income consistent with the performance of the underlying index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region